194 related articles for article (PubMed ID: 31151281)
1. Telomerase Inhibitor TMPyP4 Alters Adhesion and Migration of Breast-Cancer Cells MCF7 and MDA-MB-231.
Konieczna N; Romaniuk-Drapała A; Lisiak N; Totoń E; Paszel-Jaworska A; Kaczmarek M; Rubiś B
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151281
[TBL] [Abstract][Full Text] [Related]
2. hTERT Downregulation Attenuates Resistance to DOX, Impairs FAK-Mediated Adhesion, and Leads to Autophagy Induction in Breast Cancer Cells.
Romaniuk-Drapała A; Totoń E; Konieczna N; Machnik M; Barczak W; Kowal D; Kopczyński P; Kaczmarek M; Rubiś B
Cells; 2021 Apr; 10(4):. PubMed ID: 33920284
[TBL] [Abstract][Full Text] [Related]
3. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D
Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725
[TBL] [Abstract][Full Text] [Related]
4. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.
Izbicka E; Wheelhouse RT; Raymond E; Davidson KK; Lawrence RA; Sun D; Windle BE; Hurley LH; Von Hoff DD
Cancer Res; 1999 Feb; 59(3):639-44. PubMed ID: 9973212
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines.
Fujimori J; Matsuo T; Shimose S; Kubo T; Ishikawa M; Yasunaga Y; Ochi M
J Orthop Res; 2011 Nov; 29(11):1707-11. PubMed ID: 21590716
[TBL] [Abstract][Full Text] [Related]
6. The different biological effects of TMPyP4 and cisplatin in the inflammatory microenvironment of osteosarcoma are attributed to G-quadruplex.
Chen J; Jin X; Mei Y; Shen Z; Zhu J; Shi H; Wang M; Zheng X; Liang G
Cell Prolif; 2021 Sep; 54(9):e13101. PubMed ID: 34296479
[TBL] [Abstract][Full Text] [Related]
7. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of TMPyP4 interacting G-quadruplex in retinoblastoma cell lines.
Mikami-Terao Y; Akiyama M; Yuza Y; Yanagisawa T; Yamada O; Kawano T; Agawa M; Ida H; Yamada H
Exp Eye Res; 2009 Aug; 89(2):200-8. PubMed ID: 19328784
[TBL] [Abstract][Full Text] [Related]
9. The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.
Grand CL; Han H; Muñoz RM; Weitman S; Von Hoff DD; Hurley LH; Bearss DJ
Mol Cancer Ther; 2002 Jun; 1(8):565-73. PubMed ID: 12479216
[TBL] [Abstract][Full Text] [Related]
10. TMPyP4 promotes cancer cell migration at low doses, but induces cell death at high doses.
Zheng XH; Nie X; Liu HY; Fang YM; Zhao Y; Xia LX
Sci Rep; 2016 May; 6():26592. PubMed ID: 27221067
[TBL] [Abstract][Full Text] [Related]
11. G-Quadruplex ligands: Potent inhibitors of telomerase activity and cell proliferation in Plasmodium falciparum.
Calvo EP; Wasserman M
Mol Biochem Parasitol; 2016 May; 207(1):33-8. PubMed ID: 27217226
[TBL] [Abstract][Full Text] [Related]
12. Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma.
Shammas MA; Shmookler Reis RJ; Akiyama M; Koley H; Chauhan D; Hideshima T; Goyal RK; Hurley LH; Anderson KC; Munshi NC
Mol Cancer Ther; 2003 Sep; 2(9):825-33. PubMed ID: 14555701
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of G-quadruplex-interactive agent TMPyP4 in K562 leukemic cells.
Mikami-Terao Y; Akiyama M; Yuza Y; Yanagisawa T; Yamada O; Yamada H
Cancer Lett; 2008 Mar; 261(2):226-34. PubMed ID: 18096315
[TBL] [Abstract][Full Text] [Related]
14. Novel Amphiphilic G-Quadruplex Binding Synthetic Derivative of TMPyP4 and Its Effect on Cancer Cell Proliferation and Apoptosis Induction.
Chilakamarthi U; Koteshwar D; Jinka S; Vamsi Krishna N; Sridharan K; Nagesh N; Giribabu L
Biochemistry; 2018 Nov; 57(46):6514-6527. PubMed ID: 30369235
[TBL] [Abstract][Full Text] [Related]
15. Telomerase as a Possible Candidate Targeting Therapy in Different Breast Cancer Cell Lines.
Aboelela S; Ashmawy A; Shaarawy S; El-Hefny M; Medhat A
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2243-2250. PubMed ID: 32856851
[TBL] [Abstract][Full Text] [Related]
16. Aloe emodin inhibits telomerase activity in breast cancer cells: transcriptional and enzymological mechanism.
Wang S; Yan WW; He M; Wei D; Long ZJ; Tao YM
Pharmacol Rep; 2020 Oct; 72(5):1383-1396. PubMed ID: 32207090
[TBL] [Abstract][Full Text] [Related]
17. Quadruplex-interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase.
Shi DF; Wheelhouse RT; Sun D; Hurley LH
J Med Chem; 2001 Dec; 44(26):4509-23. PubMed ID: 11741471
[TBL] [Abstract][Full Text] [Related]
18. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
Raymond E; Sun D; Izbicka E; Mangold G; Silvas E; Windle B; Sharma S; Soda H; Laurence R; Davidson K; Von Hoff DD
Br J Cancer; 1999 Jul; 80(9):1332-41. PubMed ID: 10424733
[TBL] [Abstract][Full Text] [Related]
19. Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos.
Izbicka E; Nishioka D; Marcell V; Raymond E; Davidson KK; Lawrence RA; Wheelhouse RT; Hurley LH; Wu RS; Von Hoff DD
Anticancer Drug Des; 1999 Aug; 14(4):355-65. PubMed ID: 10625928
[TBL] [Abstract][Full Text] [Related]
20. MST-312 Alters Telomere Dynamics, Gene Expression Profiles and Growth in Human Breast Cancer Cells.
Gurung RL; Lim SN; Low GK; Hande MP
J Nutrigenet Nutrigenomics; 2014; 7(4-6):283-98. PubMed ID: 26022559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
